Drug · DIN 02569795
XDENO
SINGLE-USE VIAL
Authorized, not yet reported as sold
Authorized for sale in Canada; the company has not yet told Health Canada that it is on the market.
Status Approved since July 10, 2026.
- Drug Identification Number (DIN)
- 02569795
- Company (DIN owner)
- JAMP Pharma CorporationBoucherville, Quebec, Canada
- Schedule
- Prescription; Schedule D
- Dosage form
- Solution
- Route
- Subcutaneous
- Therapeutic class (ATC)
- Denosumab M05BX04
- Class
- Human
- Record last updated
- July 22, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| DENOSUMAB | 120 MG | 1.7 ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- July 10, 2026: NOC 37879New Drug Submission (NDS)